Dr Sunita KC Basnet

University Transfer People, Talent and Culture

City West Campus (HB7-25)
tel +61 8 830 21664

email Sunita.KCBasnet@unisa.edu.au

Research Degree Supervisor

Research

Research focus

Medicinal and Biomolecular Chemistry
Pharmacology and Pharmaceutical Sciences
Organic Chemistry
Theoretical and Computational Chemistry
Biochemistry and Cell Biology

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus

Open access indicates that an output is open access.

Journal Articles

Year	Output
2025	Mekonnen, LB, Teo, T, Noll, B, Rahaman, MH, Lenjisa, J, Basnet, S, Hassankhani, R, Milne, R, Gliddon, BL, Tea, MN, Pitson, SM, Zhou, Y, Wei, L, Wang, H, Liu, J, Zhou, X, Wang, K & Wang, S 2025, 'A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma', Biomedicine and Pharmacotherapy, vol. 189, article no. 118340, pp. 1-16. Open access
2023	Chen, R, Hassankhani, R, Long, Y, Basnet, SK, Teo, T, Yang, Y, Mekonnen, L, Yu, M & Wang, S 2023, 'Discovery of potent Inhibitors of cyclin-dependent kinases 7 and 9: design, synthesis, structure-activity relationship analysis and biological evaluation', ChemMedChem: chemistry enabling drug discovery, vol. 18, no. 3, article no. e202200582. Open access 5 5 11
2023	Fanta, BS, Mekonnen, L, Basnet, SK, Teo, T, Lenjisa, J, Khair, NZ, Kou, L, Tadesse, S, Sykes, MJ, Yu, M & Wang, S 2023, '2-Anilino-4-(1-methyl-1H-pyrazol-4-yl)pyrimidine-derived CDK2 inhibitors as anticancer agents: design, synthesis & evaluation', Bioorganic and Medicinal Chemistry, vol. 80, article no. 117158, pp. 1-15. Open access 15 15 1
2023	Sintayehu Fanta, B, Lenjisa, J, Teo, T, Kou, L, Mekonnen, L, Yang, Y, Basnet, SK, Hassankhani, R, Sykes, MJ, Yu, M & Wang, S 2023, 'Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-derived CDK2 inhibitors as potential anticancer agents: design, synthesis, and evaluation', Molecules, vol. 28, no. 7, article no. 2951, pp. 1-21. Open access 5 4 2
2022	Anshabo, AT, Bantie, L, Diab, S, Lenjisa, J, Kebede, A, Long, Y, Heinemann, G, Karanjia, J, Noll, B, Basnet, SK, Li, M, Milne, R, Albrecht, H & Wang, S 2022, 'An orally bioavailable and highly efficacious inhibitor of CDK9/FLT3 for the treatment of acute myeloid leukemia', Cancers, vol. 14, no. 5, article no. 1113, pp. 1-19. Open access 12 10 23
2021	Long, Y, Yu, M, Ochnik, AM, Karanjia, JD, KC Basnet, S, Kebede, AA, Kou, L & Wang, S 2021, 'Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations', European Journal of Medicinal Chemistry, vol. 213, article no. 113215, pp. 1-18. Open access 13 11 1
2019	Abdelaziz, AM, Diab, S, Islam, S, KC Basnet, S, Noll, B, Li, P, Mekonnen, LB, Lu, J, Albrecht, H, Milne, RW, Gerber, C, Yu, M & Wang, S 2019, 'Discovery of n-phenyl-4-(1h-pyrrol-3-yl)pyrimidin-2-amine derivatives as potent mnk2 inhibitors: design, synthesis, sar analysis, and evaluation of in vitro anti-leukaemic activity', Medicinal Chemistry, vol. 15, no. 6, pp. 600-621. 6 5
2019	Abdelaziz, AM, MC Basnet, S, Islam, S, Li, M, Tadesse, S, Albrecht, H, Gerber, C, Yu, M & Wang, S 2019, 'Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors', Bioorganic and Medicinal Chemistry Letters, vol. 29, no. 18, pp. 2650-2654. Open access 10 10 3
2019	Khair, NZ, Lenjisa, JL, Tadesse, S, Kumarasiri, M, Basnet, SK, Mekonnen, LB, Li, M, Diab, S, Sykes, MJ, Albrecht, H, Milne, R & Wang, S 2019, 'Discovery of CDK5 inhibitors through structure-guided approach', ACS Medicinal Chemistry Letters, vol. 10, no. 5, pp. 786-791. Open access 23 21 1
2017	Diab, S, Abdelaziz, AM, Li, P, Teo, T, Basnet, SK, Noll, B, Rahaman, MH, Lu, J, Hou, J, Yu, M, Le, BT, Albrecht, H, Milne, RW & Wang, S 2017, 'Dual inhibition of Mnk2 and FLT3 for potential treatment of acute myeloid leukaemia', European Journal of Medicinal Chemistry, vol. 139, pp. 762-772. Open access 23 22
2017	Kumarasiri, M, Teo, T, Yu, M, Philip, S, Basnet, SK, Albrecht, H, Sykes, MJ, Wang, P & Wang, S 2017, 'In search of novel CDK8 inhibitors by virtual screening', Journal of Chemical Information and Modeling, vol. 57, no. 3, pp. 413-416. 15 16 2
2017	Zeleke, S, Yu, M, Mekonnen, LB, Lam, F, Islam, S, Tomusange, K, Rahaman, MH, Noll, B, MC Basnet, S, Teo, T, Albrecht, H, Milne, R & Wang, S 2017, 'Highly potent, selective, and orally bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine cyclin-dependent kinases 4 and 6 inhibitors as anticancer drug candidates: design, synthesis, and evaluation', Journal of Medicinal Chemistry, vol. 60, no. 5, pp. 1892-1915. Open access 72 65 9
2016	Diab, S, Li, P, MC Basnet, S, Lu, J, Yu, M, Albrecht, H, Milne, RW & Wang, S 2016, 'Unveiling new chemical scaffolds as Mnk inhibitors', Future Medicinal Chemistry, vol. 8, no. 3, pp. 271-285. 22 20 3
2016	Li, P, Diab, S, Yu, M, Adams, J, Islam, S, MC Basnet, S, Albrecht, H, Milne, RW & Wang, S 2016, 'Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells', Oncotarget, vol.7, no.35, pp.1-15. Open access 22 22 3
2015	MC Basnet, S, Diab, S, Schmid, R, Yu, M, Yang, Y, Gillam, TA, Teo, T, Li, P, Peat, T, Albrecht, H & Wang, S 2015, 'Identification of a highly conserved allosteric binding site on Mnk1 and Mnk2', Molecular Pharmacology, vol. 88, no. 5, pp. 935-948. Open access 15 15 3
2015	Teo, T, Lam, F, Yu, M, Yang, Y, MC Basnet, S, Albrecht, H, Sykes, M & Wang, S 2015, 'Pharmacologic inhibition of MNKs in acute myeloid leukemia', Molecular Pharmacology, vol. 88, no. 2, pp. 380-389. Open access 31 27 6
2015	Teo, T, Yang, Y, Yu, M, MC Basnet, S, Gillam, T, Hou, J, Schmid, R, Kumarasiri, M, Diab, S, Albrecht, H, Sykes, M & Wang, S 2015, 'An integrated approach for discovery of highly potent and selective Mnk inhibitors: screening, synthesis and SAR analysis', European Journal of Medicinal Chemistry, vol. 103, pp. 539-550. 31 27 7
2015	Yu, M, Li, P, MC Basnet, S, Kumarasiri, M, Diab, S, Teo, T, Albrecht, H & Wang, S 2015, 'Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d[pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure-activity relationship analysis and biological evaluation', European Journal of Medicinal Chemistry, vol. 95, pp. 116-126. 37 37 3
2014	Diab, S, Teo, THS, Kumarasiri, M, Li, P, Yu, M, Lam, F, MC Basnet, S, Sykes, MJ, Albrecht, H, Milne, R & Wang, S 2014, 'Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors : synthesis, SAR analysis and biological evaluation', ChemMedChem: chemistry enabling drug discovery, vol. 9, no. 5, pp. 962-972. Open access 80 76

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
CSIRO Australia (Commonwealth Scientific Industrial Research organisation)	AUSTRALIA
University of South Australia	AUSTRALIA
Yabao Pharmaceutical Group Co., Ltd	CHINA

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Preclinical evaluation of transcription regulator/ tyrosine kinase inhibitors for the treatment of cancer	Current

more less

Dr Sunita KC Basnet

About me

About me

People, Talent and Culture

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Projects

Outputs

Journal Articles

External engagement & recognition

Collaborations

Collaborations

Teaching & student supervision

Courses and programs

Research degree supervision

Gallery